CD8A and nonpapillary renal cell carcinoma: Specifically, CIBERSORT.CD8 only showed significant associations with clinical response in ccRCC (Figure 3B, p = 0.027 in the Miao et al., 2018 study (ICB), Wilcoxon Rank Sum Test) and IPS only in UC patients (Figure 3C and Figure S12, p = 0.006 in the Mariathasan et al., 2018 report, Wilcoxon Rank Sum Test).